no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses
|
Eldridge, John H. |
|
|
39 |
38 |
p. 5436-5441 |
article |
2 |
Agreement between state registry, health record, and self-report of influenza vaccination
|
Petrie, Joshua G. |
|
|
39 |
38 |
p. 5341-5345 |
article |
3 |
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age
|
Klein, Nicola P. |
|
|
39 |
38 |
p. 5428-5435 |
article |
4 |
Burden of rotavirus disease in young children in Iceland – Time to vaccinate?
|
Kristinsdottir, Iris |
|
|
39 |
38 |
p. 5422-5427 |
article |
5 |
Children are the key to the Endgame: A case for routine pediatric COVID vaccination
|
Schleiss, Mark R. |
|
|
39 |
38 |
p. 5333-5336 |
article |
6 |
Corrigendum to ‘Are refugees arriving in Denmark an under-immunised group for measles? A cross-sectional serology study’ [Vaccine 38 (2020) 2788–2794]
|
Hvass, Anne Mette Fløe |
|
|
39 |
38 |
p. 5451 |
article |
7 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
38 |
p. IFC |
article |
8 |
Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles
|
Stinson, Jordan A. |
|
|
39 |
38 |
p. 5410-5421 |
article |
9 |
Exploring socio-demographic and geospatial variation in human papillomavirus vaccination uptake in Virginia
|
Staples, Jeanine N. |
|
|
39 |
38 |
p. 5385-5390 |
article |
10 |
ICD-10 anaphylaxis algorithm and the estimate of vaccine-attributable anaphylaxis incidence in Medicare
|
Goud, Ravi |
|
|
39 |
38 |
p. 5368-5375 |
article |
11 |
Implementing vaccination policies based upon scientific evidence in Japan
|
Yoshikawa, Tetsushi |
|
|
39 |
38 |
p. 5447-5450 |
article |
12 |
Improved immunologic responses to heterologous influenza strains in children with low preexisting antibody response vaccinated with MF59-adjuvanted influenza vaccine
|
Palladino, Giuseppe |
|
|
39 |
38 |
p. 5351-5357 |
article |
13 |
Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination
|
Grupel, Daniel |
|
|
39 |
38 |
p. 5337-5340 |
article |
14 |
Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants
|
Britton, Kathryn J. |
|
|
39 |
38 |
p. 5401-5409 |
article |
15 |
Measles infection in persons with secondary vaccine failure, New York City, 2018–19
|
Iwamoto, Martha |
|
|
39 |
38 |
p. 5346-5350 |
article |
16 |
Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models
|
Webster, Helen |
|
|
39 |
38 |
p. 5358-5367 |
article |
17 |
Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study)
|
Jõgi, Piia |
|
|
39 |
38 |
p. 5376-5384 |
article |
18 |
The fecal microbiome and rotavirus vaccine immunogenicity in rural Zimbabwean infants
|
Robertson, Ruairi C. |
|
|
39 |
38 |
p. 5391-5400 |
article |
19 |
Was Aldo Castellani the inventor of combined and polyvalent vaccines?
|
Borghi, Luca |
|
|
39 |
38 |
p. 5442-5446 |
article |